Sangamo Therapeutics
SGMO
#8849
Rank
NZ$0.26 B
Marketcap
NZ$0.77
Share price
-1.98%
Change (1 day)
-76.59%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -NZ$0.19 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are NZ$32.87 Million. In 2024 the company made an earning of -NZ$0.17 Billion, an increase over its 2023 earnings that were of -NZ$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.19 Billion11.48%
2024 -NZ$0.17 Billion-17.27%
2023 -NZ$0.21 Billion-40.88%
2022 -NZ$0.35 Billion9.79%
2021 -NZ$0.32 Billion41.52%
2020 -NZ$0.23 Billion23.17%
2019 -NZ$0.19 Billion36.33%
2018 -NZ$0.14 Billion36.89%
2017 -NZ$97.06 Million-22.32%
2016 -NZ$0.13 Billion54.86%
2015 -NZ$80.69 Million75.62%
2014 -NZ$45.95 Million0.13%
2013 -NZ$45.89 Million
2011 -NZ$61.69 Million43.66%
2010 -NZ$42.94 Million28.52%
2009 -NZ$33.42 Million-23.55%
2008 -NZ$43.71 Million2.45%
2007 -NZ$42.66 Million19.5%
2006 -NZ$35.7 Million50.78%
2005 -NZ$23.68 Million75%
2004 -NZ$13.53 Million-33.25%
2003 -NZ$20.27 Million-62.27%
2002 -NZ$53.72 Million102.82%
2001 -NZ$26.49 Million23.21%
2000 -NZ$21.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
NZ$17.02 B-9,167.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.22 B-219.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.19 B-7,661.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$3.27 B-1,846.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-NZ$1.29 Billion 582.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.78 B-29,814.01%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$1.16 B-723.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.76 B-21,278.43%๐Ÿ‡บ๐Ÿ‡ธ USA